^
Association details:
Biomarker:No biomarker
Cancer:Biliary Tract Cancer
Drug:Stivarga (regorafenib) (Multi-tyrosine kinase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Biliary Tract Cancers: PRINCIPLES OF SYSTEMIC THERAPY…Other Recommended Regimens…Regorafenib